Scancell Holdings plc (LON:SCLP – Get Free Report) shares reached a new 52-week low on Thursday . The company traded as low as GBX 7.94 ($0.10) and last traded at GBX 8.40 ($0.11), with a volume of 298429 shares. The stock had previously closed at GBX 8.45 ($0.11).
Scancell Trading Up 2.7 %
The stock has a market capitalization of £89.33 million, a P/E ratio of -13.22 and a beta of 0.35. The business has a 50 day simple moving average of GBX 9.36 and a 200-day simple moving average of GBX 12.50. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42.
Scancell (LON:SCLP – Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. On average, analysts predict that Scancell Holdings plc will post -2.5361112 EPS for the current year.
Scancell Company Profile
Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
Recommended Stories
- Five stocks we like better than Scancell
- Utilities Stocks Explained – How and Why to Invest in Utilities
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks to Buy While Others Stay on the Sidelines
- Following Congress Stock Trades
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
